Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 224 participants.
Also called NCT05459974
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 224 participants
- Sponsor
- Registry
-
NCT05459974
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT05459974. Randomized; quadruple masking; primary purpose treatment. Start 2022-06-20 (actual); primary completion 2023-11-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Use of Colchicine to Decrease Atrial Fibrillation Recurrence After Ablation
- Condition
- Atrial Fibrillation
- Intervention (Drug)
- Colchicine 0.6 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- Stony Brook University
Record details
- Record id
cardio:ct-nct05459974- Content hash
d7c01a5c26f5e47fe8b49c771ecde520a8158f80b49bfd1201a1fb470cac03dd